Cargando…
Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
The prevalence of nonalcoholic fatty liver disease and the consequent burden of metabolic syndrome have increased in recent years. Although the pathogenesis of nonalcoholic fatty liver disease is not completely understood, it is thought to be the hepatic manifestation of the dysregulation of insulin...
Autores principales: | Bibbò, Stefano, Ianiro, Gianluca, Dore, Maria Pina, Simonelli, Claudia, Newton, Estelle E., Cammarota, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833468/ https://www.ncbi.nlm.nih.gov/pubmed/29563854 http://dx.doi.org/10.1155/2018/9321643 |
Ejemplares similares
-
Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018) -
Fecal Microbiota Transplantation in Inflammatory Bowel Disease: Beyond the Excitement
por: Ianiro, Gianluca, et al.
Publicado: (2014) -
Gut microbiota and immunotherapy of renal cell carcinoma
por: Bibbò, Stefano, et al.
Publicado: (2023) -
Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018) -
Role of gut microbiome on immunotherapy efficacy in melanoma
por: Bibbò, Stefano, et al.
Publicado: (2021)